|
Tabla 2: Análisis bivariado para determinar el equilibrio neuromuscular según las características clínicas (edad, sexo, maloclusión esquelética, biotipo facial, dolor miofacial e IMC) medido antes del uso de férulas en todos los pacientes (N = 52). Table 2: Bivariate analysis to detrmine neuromuscular balance according to the clinical characteristics (age, sex, skeletal malocclusion, facial biotype, myofacial pain and BMI) measured before splint use in all patients (N = 52). |
||||
|
Edad (años) |
n (%) |
Equilibrio neuromuscular |
p (< 0.05) |
|
|
Coef (IC) -0.014 (-0.04-0.01) |
p (< 0.05) 0.375* |
|||
|
Disminuye n (%) |
Aumenta n (%) |
|||
|
Sexo |
||||
|
Hombres |
13 µV (25) |
9 µV (19) |
2 µV (4) |
|
|
Mujeres |
39 µV (75) |
18 µV (39) |
17 µV (19) |
0.074‡,§ |
|
Maloclusión esquelética |
||||
|
Clase I |
12 µV (23) |
4 µV (9) |
6 µV (13) |
|
|
Clase II |
27 µV (48) |
16 µV (35) |
9 µV (19) |
0.398‡,§ |
|
Clase III |
13 µV (25) |
7 µV (19) |
4 µV (9) |
|
|
Biotipo facial |
||||
|
Dolicofacial |
35 µV (67) |
18 µV (39) |
12 µV (26) |
|
|
Mesofacial |
7 µV (13) |
3 µV (6) |
4 µV (9) |
0.612‡,§ |
|
Braquifacial |
10 µV (19) |
6 µV (13) |
3 µV (7) |
|
|
Dolor miofascial |
||||
|
Sí |
24 µV (46) |
13 µV (28) |
9 µV (19) |
|
|
No |
28 µV (54) |
14 µV (30) |
10 µV (22) |
0.958‡,§ |
|
IMC (kg/m2) |
||||
|
Bajo peso |
8 µV (16) |
2 µV (4) |
2 µV (4) |
0.622‡,§ |
|
Normal |
35 µV (67) |
20 µV (43) |
12 µV (26) |
|
|
Sobrepeso |
9 µV (17) |
5 µV (11) |
4 µV (9) |
|
|
* Regresión lineal. ‡ χ2. § Escala de Fisher. |
||||